Short-term joint and skin improvements in psoriatic arthritis may not be influenced by the timing of biologic therapy initiation.

First MTPJ arthrodesis offers a superior reduction in walking-related pain for adults 40 years and older with painful hallux rigidus.

Pregnant women with rheumatoid arthritis face an increased risk for preterm birth and small for gestational age newborns, according to recent data.

Patient reassurance that symptoms are normal can lead individuals to incorrectly infer that medical treatment is unnecessary ...

Researchers evaluated the effects of biologic and targeted synthetic DMARDs on patient-reported outcomes in rheumatoid arthritis.

Researchers evaluated the efficacy of secukinumab plus a glucocorticoid taper for achieving sustained remission in polymyalgia rheumatica.

An executive order called for a reduction in childhood vaccines, prompting pushback from health care providers.

Continued low-dose glucocorticoid maintenance therapy in ANCA-associated vasculitis does not reduce major relapse risk but can increase damage accrual.

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

Despite a higher symptom burden, multimodal and multidisciplinary treatment is underutilized in older patients with chronic pain ...

Regardless of patient ethnicity or socioeconomic status, disease activity improved over 6 months after the initiation of a tumor necrosis factor inhibitor for juvenile idiopathic arthritis.

Individuals with atopic dermatitis have an increased risk for herpes zoster — a risk that increases with atopic dermatitis severity.